BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry
暂无分享,去创建一个
Annette Lee | F. Couch | O. Olopade | T. Rebbeck | B. Karlan | W. Foulkes | D. Easton | M. Greene | K. Offit | A. Antoniou | G. Chenevix-Trench | K. Nathanson | J. Garber | C. Isaacs | I. Andrulis | G. Glendon | A. Toland | S. Neuhausen | J. Kirk | L. McGuffog | N. Tung | P. Ganz | P. Hulick | S. Domchek | D. Huo | K. Lu | M. Daly | J. Balmaña | J. Weitzel | M. Tischkowitz | F. Lesueur | E. J. van Rensburg | A. Kwong | T. Friebel | A. Vega | P. Sharma | Amie M. Blanco | R. Jankowitz | M. Parsons | E. Palmero | T. Maga | K. Hoskins | Priyanka Sharma | K. Lu | K. Lu
[1] T. Walsh,et al. Inherited Breast Cancer in Nigerian Women , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] M. Mzibri,et al. BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso , 2018, Journal of public health in Africa.
[3] Annette Lee,et al. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations , 2018, Human mutation.
[4] M. Sekine,et al. Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan , 2017, Journal of Human Genetics.
[5] M. Hassan,et al. Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer , 2017, BMC Medical Genetics.
[6] S. Grover,et al. An update on the management of breast cancer in Africa , 2017, Infectious Agents and Cancer.
[7] Olufunmilayo I. Olopade,et al. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women , 2016, Breast Cancer Research.
[8] S. Narod,et al. A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago , 2016, Breast Cancer Research and Treatment.
[9] A. Monteiro,et al. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida , 2015, Cancer.
[10] A. Vral,et al. BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer , 2015, BMC Cancer.
[11] C. Isaacs,et al. Deleterious BRCA1/2 mutations in an urban population of Black women , 2015, Breast Cancer Research and Treatment.
[12] T. Walsh,et al. Inherited predisposition to breast cancer among African American women , 2014, Breast Cancer Research and Treatment.
[13] E. van Limbergen,et al. From the set-up of a screening program of breast cancer patients to the identification of the first BRCA mutation in the DR Congo , 2014, BMC Public Health.
[14] P. Blasio,et al. BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan , 2014, Familial Cancer.
[15] Akbari,et al. The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas , 2014, Clinical genetics.
[16] M. Mzibri,et al. Breast cancer in Morocco: a literature review. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[17] Soo-Hwang Teo,et al. Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations , 2012, European Journal of Human Genetics.
[18] Lawal AbdulRazzaq Oluwagbemiga,et al. Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? – a systematic review , 2012, SpringerPlus.
[19] O. Olopade,et al. High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients , 2012, International journal of cancer.
[20] M. C. Leske,et al. Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry , 2012, Breast Cancer Research and Treatment.
[21] W. Foulkes,et al. A founder BRCA2 mutation in non‐Afrikaner breast cancer patients of the Western Cape of South Africa , 2012, Clinical genetics.
[22] O. Díez,et al. Novel BRCA1 deleterious mutation (c.1949_1950delTA) in a woman of Senegalese descent with triple-negative early-onset breast cancer. , 2011, Oncology letters.
[23] Rosalind Eeles,et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. , 2010, JAMA.
[24] O. Olopade,et al. Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian population , 2010, Breast Cancer Research and Treatment.
[25] R. Janavicius. Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control , 2010, EPMA Journal.
[26] S. Narod,et al. A high prevalence of BRCA1 mutations among breast cancer patients from the Bahamas , 2010, Breast Cancer Research and Treatment.
[27] D. Toppmeyer,et al. Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[28] B. Ward,et al. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancer , 2009, Cancer.
[29] Susan M. Domchek,et al. Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers , 2009, Journal of the National Cancer Institute.
[30] S. Vadaparampil,et al. BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies. , 2008, Genetic testing.
[31] Olga Anczuków,et al. Does the nonsense‐mediated mRNA decay mechanism prevent the synthesis of truncated BRCA1, CHK2, and p53 proteins? , 2008, Human mutation.
[32] C. Adebamowo,et al. Evidence for an ancient BRCA1 mutation in breast cancer patients of yoruban ancestry , 2008, Familial Cancer.
[33] B. Kingham,et al. BRCA1 E1644X: a deleterious mutation in an African American individual with early onset breast cancer , 2008, Breast Cancer Research and Treatment.
[34] Alice S Whittemore,et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. , 2007, JAMA.
[35] Georgia Chenevix-Trench,et al. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) , 2007, Breast Cancer Research.
[36] T. Rebbeck,et al. Prophylactic oophorectomy in women at increased cancer risk , 2007, Current opinion in obstetrics & gynecology.
[37] R. Mariani-Costantini,et al. BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors , 2007, Breast Cancer Research and Treatment.
[38] Olga Anczuków,et al. The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon , 2006, Human mutation.
[39] O. Olopade,et al. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. , 2006, The Lancet. Oncology.
[40] T. Rebbeck,et al. Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriers. , 2006, Journal of the National Comprehensive Cancer Network : JNCCN.
[41] S. Tavtigian,et al. Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene? , 2006, Oncogene.
[42] O. Olopade,et al. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] L. Esserman,et al. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. , 2005, JAMA.
[44] C. Rotimi,et al. Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients , 2005, Journal of Medical Genetics.
[45] R. Sutphen,et al. BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[46] Thorunn Rafnar,et al. The Icelandic founder mutation BRCA2 999del5: analysis of expression , 2004, Breast Cancer Research.
[47] G. Dunston,et al. Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases , 2003, Human Genetics.
[48] O. Olopade,et al. Breast cancer genetics in African Americans , 2003, Cancer.
[49] D. Stoppa-Lyonnet,et al. The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. , 2002, Human molecular genetics.
[50] Olufunmilayo I. Olopade,et al. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer , 2000, Human Genetics.
[51] J. Vadgama,et al. Mutation analysis of BRCA1 gene in African-American patients with breast cancer. , 2000, Journal of the National Medical Association.
[52] A. Godwin,et al. Novel germline BRCA1 mutation (155del4) in an African American with early‐onset breast cancer , 1999, Human mutation.
[53] R. Modali,et al. BRCA1 mutations in African Americans , 1999, Human Genetics.
[54] A. Ganguly,et al. High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families , 1998, Human Genetics.
[55] P. Laurent-Puig,et al. BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. , 1997, American journal of human genetics.
[56] S. Cummings,et al. Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. , 1997, American journal of human genetics.
[57] Francis S. Collins,et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer , 1994, Nature Genetics.
[58] M. Skolnick,et al. BRCA1 mutations in primary breast and ovarian carcinomas. , 1994, Science.
[59] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.